Goutorbe Philippe, Montcriol Ambroise, Lacroix Guillaume, Bordes Julien, Meaudre Eric, Souraud Jean-Baptiste
Philippe Goutorbe MD, Clinical Specialist, Head of Department of Intensive Care, Sainte Anne Military Teaching Hospital, Toulon, France
Ambroise Montcriol MD, Clinical Specialist, ICU, Sainte Anne Military Teaching Hospital.
Ann Pharmacother. 2011 Feb;45(2):e13. doi: 10.1345/aph.1M547.
To describe a case of extensive intestinal necrosis with oral intake of calcium polystyrene sulfonate without sorbitol.
A 73-year-old woman was admitted to the emergency department with abdominal pain. Abdominal computed tomography (CT) scan showed widespread dilatation of the bowel. The diagnosis of acute colonic pseudoobstruction was made. On day 3, her serum potassium level rose to 5.6 mEq/L. It was treated with hydrocortisone 100 mg/day and calcium polystyrene sulfonate 15 g/day via nasogastric tube from day 3 to day 6. On day 6, the severe abdominal pain recurred, with abdominal tenderness. CT scan showed pneumoperitoneum and peritoneal effusion. At surgery, 2 lenticular jejunal perforations and an ischemic cecum were found. Microscopic findings indicated that the transmural abscess contained massive inflammatory infiltrate and the cecal mucosa showed ulceration and inflammation with a fibrinous and purulent coating. Small gray-purple or blue angulated crystals were embedded in the cecal and most of the jejunal mucosal ulcers. On day 19, the patient died of multiple organ failure after her third laparotomy.
Ion-exchanging resins are given orally or by retention enema for the treatment of hyperkalemia. The most commonly used and best-established resin is sodium polystyrene sulfonate. However, it is known to promote colonic necrosis when sorbitol is also given or especially in patients with renal failure or postoperative ileus. Calcium polystyrene sulfonate is another ion-exchange resin. There are few reports of adverse effects in the literature. Our case is interesting for 2 reasons: the resin given was calcium polystyrene sulfonate and sorbitol was not used.
Like sodium polystyrene sulfonate, calcium polystyrene sulfonate is an ion-exchanging resin that can promote bowel necrosis. We believe that it should not be used with sorbitol or when bowel transit time is slowed.
描述一例口服不含山梨醇的聚苯乙烯磺酸钙后发生广泛肠坏死的病例。
一名73岁女性因腹痛入住急诊科。腹部计算机断层扫描(CT)显示肠道广泛扩张。诊断为急性结肠假性梗阻。第3天,她的血清钾水平升至5.6 mEq/L。从第3天到第6天,通过鼻胃管给予她100 mg/天的氢化可的松和15 g/天的聚苯乙烯磺酸钙进行治疗。第6天,再次出现严重腹痛,伴有腹部压痛。CT扫描显示气腹和腹腔积液。手术中发现2处扁豆状空肠穿孔和1处缺血性盲肠。显微镜检查结果显示,透壁脓肿含有大量炎性浸润,盲肠黏膜显示溃疡和炎症,伴有纤维蛋白性和脓性覆盖物。小的灰紫色或蓝色角状晶体嵌入盲肠和大部分空肠黏膜溃疡中。第19天,患者在第三次剖腹手术后死于多器官功能衰竭。
离子交换树脂口服或通过保留灌肠用于治疗高钾血症。最常用且最成熟的树脂是聚苯乙烯磺酸钠。然而,已知当同时给予山梨醇时,尤其是在肾衰竭或术后肠梗阻患者中,它会促进结肠坏死。聚苯乙烯磺酸钙是另一种离子交换树脂。文献中关于不良反应的报道很少。我们的病例有趣有两个原因:给予的树脂是聚苯乙烯磺酸钙且未使用山梨醇。
与聚苯乙烯磺酸钠一样,聚苯乙烯磺酸钙是一种可促进肠坏死的离子交换树脂。我们认为它不应与山梨醇一起使用,或在肠道转运时间减慢时使用。